Treatment and Outcomes of Acute Coronary Syndrome in the Cancer Population
- 15 May 2012
- journal article
- Published by Wiley in Clinical Cardiology
- Vol. 35 (7), 443-450
- https://doi.org/10.1002/clc.22007
Abstract
Background: Randomized trials have established the benefit of medical therapy and revascularization in the treatment of acute myocardial infarction (MI). Cancer and cardiovascular disease are the 2 most common diseases worldwide. In clinical practice, cancer patients are frequently afflicted with MI. The benefit of medical and/or revascularization therapy in the cancer population with MI is less well known. Hypothesis: Medical and revascularization therapy reduces mortality in cancer patients with MI. Methods: After approval by the institutional review board, we retrospectively reviewed all patients with a discharge diagnosis of acute MI who were admitted to the University of Texas MD Anderson Cancer Center between December 2000 and October 2006 and evaluated the association between cardiac treatments with survival outcomes. Results: A total of 456 patients with a discharge diagnosis of acute MI were identified and included in the study, of which 386 had non–ST‐segment elevation MI (NSTEMI) and 70 had ST‐segment elevation MI (STEMI). Compared with patients with NSTEMI, patients who had STEMI were more often prescribed aspirin (66% vs 43%; P = 0.004), β‐blockers (61% vs 46%; P = 0.018), and thrombolytic therapy (9% vs 0.3%; P = 0.0001). In the multivariable analysis, aspirin use was associated with a 23% decreased risk of death (hazard ratio [HR]: 0.77, 95% confidence interval [CI]: 0.60‐0.98, P = 0.033) and β‐blocker use was associated with a 36% decreased risk of death (HR: 0.64, 95% CI: 0.51–0.81, P = 0.0002). Statins (HR: 0.82, P = 0.18) and catheter‐based revascularization (HR: 0.57, P = 0.09) did not have an impact on the risk of death. Compared with patients with limited cancer, advanced cancer patients were twice as likely to die (HR: 2.12, 95 CI: 1.47–3.04, P < 0.0001). Previous chemotherapy (P = 0.005) and chest radiotherapy (P = 0.017) were associated with increased 1‐year mortality, whereas hyperlipidemia (P = 0.018) was protective. Conclusions: In this study of cancer patients with MI, medical therapy with aspirin and β‐blockers was associated with improved survival. The authors have no funding, financial relationships, or conflicts of interest to disclose.Keywords
This publication has 20 references indexed in Scilit:
- Recent Trends in the Incidence, Treatment, and Outcomes of Patients with STEMI and NSTEMIAmerican Journal Of Medicine, 2011
- Acute ECG ST-segment elevation mimicking myocardial infarction in a patient with pulmonary embolismCardiovascular Ultrasound, 2010
- Computerized tomographic finding of saddle pulmonary embolism is associated with high mortality in cancer patientsInternal Medicine Journal, 2010
- 5-Fluorouracil-induced coronary vasospasmJournal of Cardiovascular Medicine, 2010
- Intracranial bleed mimicking acute myocardial infarctionInternal Medicine Journal, 2007
- Screening for Coronary Artery Disease After Mediastinal Irradiation for Hodgkin's DiseaseJournal of Clinical Oncology, 2007
- Impact of aspirin therapy in cancer patients with thrombocytopenia and acute coronary syndromesCancer, 2006
- Thrombolytic therapy for eligible elderly patients with acute myocardial infarctionAmerican Heart Journal, 2005
- Effect of age on the use of evidence-based therapies for acute myocardial infarctionAmerican Heart Journal, 2004
- Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trialsThe Lancet, 2003